Flood of cash washes over biopharma companies during the first quarter
Notwithstanding market nervousness toward the end the first quarter of 2014 the period was characterized by a tsunami of cash flooding into biotech coffers. Both global public and private companies benefited. As a result, the sector collectively raised $9.5 billion – almost double the amount raised in the same period last year according to data from BioWorld Snapshots.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter